DAWN
DAWN
NASDAQ · Biotechnology

Day One Biopharmaceuticals I

Mid-Cap Stocks Biotech Stocks Healthcare Stocks
$21.53
+0.04 (+0.19%)
As of May 3, 10:11 PM ET ·
Analyst Consensus
Hold
13
Analysts
Moderate
Coverage
Buy 0 0%
Hold 10 77%
Sell 3 23%
Price Target
Analyst Price Target +161.4% upside
Low Target $41.40
Average Target $56.28
High Target $65.73
Current Price $21.53
Current
$21.53
Target
$56.28
$41.40 $56.28 avg $65.73
Scenario Analysis
Bear Case
$41.40
92.3%
Low target
Base Case
$56.28
+161.4%
Avg target
Bull Case
$65.73
+205.3%
High target
Risk/Reward
2.2x
Favorable
Price in Context
52-Week High
$21.53
0.0% from high
52-Week Low
$5.64
+282.1% from low
Target vs 52W High
$56.28
+161.4% vs high
Next Earnings Report
May 13, 2026
2d
until earnings
EPS Est: $-0.29
Earnings in 2 days. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 40 75% $257.58 +27.8%
AMGN
Amgen Inc
 Hold 44 48% $190.87 -42.5%
GILD
Gilead Sciences Inc
 Strong Buy 39 79% $362.68 +176.2%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 39 79% $438.34 +2.0%
REGN
Regeneron Pharmaceuticals
 Strong Buy 38 79% $76.80 -89.3%
ALNY
Alnylam Pharmaceuticals Inc
 Strong Buy 36 75% $102.31 -65.3%
RVMD
Revolution Medicines Inc
 Strong Buy 27 96% $114.11 -19.5%
INSM
Insmed Inc
 Strong Buy 28 96% $143.40 +41.5%